About Yecuris
Yecuris is a company based in Tualatin (United States) founded in 2007 was acquired by Janiver Labs in January 2024.. Yecuris has raised $1.25 million across 5 funding rounds from investors including HHS and Janiver Labs. The company has 26 employees as of December 31, 2022. Yecuris offers products and services including FRG Platform, Fresh Hepatocytes, and Viral Hepatitis Research Services. Yecuris operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Tualatin, United States
- Employees 26 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Yecuris Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.25 M (USD)
in 5 rounds
-
Latest Funding Round
$453.28 K (USD), Grant
Mar 19, 2012
-
Investors
HHS
& 1 more
-
Employee Count
26
as on Dec 31, 2022
-
Acquired by
Janiver Labs
(Jan 30, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yecuris
Yecuris offers a comprehensive portfolio of products and services, including FRG Platform, Fresh Hepatocytes, and Viral Hepatitis Research Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for liver-humanized mice in gene and cell therapy research
Reagents for liver-related disease and metabolism studies
Services for testing hepatotropic agents in preclinical models
Unlock access to complete
Unlock access to complete
Funding Insights of Yecuris
Yecuris has successfully raised a total of $1.25M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $453.28 thousand completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $453,281
-
First Round
First Round
(15 Jul 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2012 | Amount | Grant - Yecuris | Valuation |
investors |
|
| Sep, 2011 | Amount | Grant - Yecuris | Valuation |
investors |
|
| Jun, 2011 | Amount | Grant - Yecuris | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Yecuris
Yecuris has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Janiver Labs. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Animal models for research are supplied with high genetic stability.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Yecuris
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Yecuris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Yecuris Comparisons
Competitors of Yecuris
Yecuris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Yecuris
Frequently Asked Questions about Yecuris
When was Yecuris founded?
Yecuris was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Yecuris located?
Yecuris is headquartered in Tualatin, United States. It is registered at Tualatin, Oregon, United States.
Is Yecuris a funded company?
Yecuris is a funded company, having raised a total of $1.25M across 5 funding rounds to date. The company's 1st funding round was a Grant of $455.75K, raised on Jul 15, 2009.
How many employees does Yecuris have?
As of Dec 31, 2022, the latest employee count at Yecuris is 26.
What does Yecuris do?
Yecuris is developing humanized liver rodent models called FRG KO in various immunocompromised backgrounds. Apart from animal models and cell lines, the company has also developed a high-content screening platform called MetAbArray, which enables the measurement of up to 10 parameters in a single assay. MetAbArray uses HepG2 cells to run the assays. Additionally, the company develops primary human and mouse hepatocytes (Yecuris HepaCur), and the CuRx line of reagents. The company offers research services to clients in the form of technical support for in-vitro and in-vivo research and development as well as consultancy for the design of animal research facilities.
Who are the top competitors of Yecuris?
Yecuris's top competitors include Abcam, Sino Biological and Meridian Bioscience.
What products or services does Yecuris offer?
Yecuris offers FRG Platform, Fresh Hepatocytes, and Viral Hepatitis Research Services.
Who are Yecuris's investors?
Yecuris has 2 investors. Key investors include HHS, and Janiver Labs.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.